SENeGal SYNbiotic (SENGSYN) Study : Dietary supplementation with a synbiotic to improve growth in early life in Senegal: an individually randomised, 2 arm, open-label, controlled study of a synbiotic in infants in Kaffrine District, Senegal.

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 29. Mai Zur Gesamtaufnahme - year:2023

Sprache:

Norwegisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Digestive System Nutritional, Metabolic, Endocrine Paediatrics;Digestive System;Nutritional, Metabolic, Endocrine;Paediatrics
Phase: Phase 2
Recruitment Status: Other
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 12-11-2020, Last updated: 2023-06-05

ICTRP ID:

PACTR202102689928613
00000213
20 012

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

CTG007558465